Mumbai, India

Jigar Kantilal Desai

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Upl Corporation Limited. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jigar Kantilal Desai. Retrieved from https://idiyas.com/inventor/jigar-kantilal-desai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jigar Kantilal Desai: Innovator in Anthranilamides Production

Introduction: Jigar Kantilal Desai is an esteemed inventor based in Mumbai, India. With a strong background in chemical processes, he has made significant contributions to the field of pharmaceuticals through his innovative inventions. His dedication to research and development has earned him recognition within the industry.

Latest Patents: Jigar Kantilal Desai holds a patent for a novel process for the preparation and purification of anthranilamides. This innovative process enhances the efficiency of production, making it a valuable asset for the pharmaceutical sector. The patent symbolizes his commitment to advancing chemical manufacturing techniques.

Career Highlights: Desai is currently employed by UPL Corporation Limited, a prominent player in the global agricultural solutions sector. His work at UPL involves leveraging his expertise in chemistry to pioneer novel processes that optimize product efficiency and safety.

Collaborations: Throughout his career, Jigar has collaborated with notable professionals, including Digish Manubhai Panchal and Jaidev Rajnikant Shroff. These collaborations have fostered a creative environment that has fueled further innovation and success in their projects.

Conclusion: Jigar Kantilal Desai's contributions to the field of anthranilamides production underscore the importance of innovation in the pharmaceutical industry. His patent reflects not only his individual genius but also the collaborative spirit inherent in research and development, marking him as a significant player in today’s chemical manufacturing landscape.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…